1. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing <scp>nonemergent</scp> percutaneous coronary intervention
- Author
-
Ehtisham Mahmud, Brian P. O'Neill, Navin K. Kapur, William W. O'Neill, Alexandra J. Lansky, E. Magnus Ohman, Jeffrey W. Moses, Theodore Schreiber, Cindy L. Grines, Amin M. Medjamia, Salvatore F. Mannino, and J.J. Popma
- Subjects
medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,Coronary artery disease ,03 medical and health sciences ,Percutaneous Coronary Intervention ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,Impella ,Retrospective Studies ,Ejection fraction ,business.industry ,Percutaneous coronary intervention ,Stroke Volume ,General Medicine ,medicine.disease ,Treatment Outcome ,Heart failure ,Ventricular assist device ,Conventional PCI ,Cardiology ,Female ,Heart-Assist Devices ,Cardiology and Cardiovascular Medicine ,business - Abstract
OBJECTIVES To compare in-hospital outcomes of bailout support to prophylactic support with percutaneous ventricular assist devices (pVAD) for high-risk nonemergent percutaneous coronary intervention (HRPCI). BACKGROUND Prophylactic support with pVAD for a HRPCI is used in patients felt to be at risk for hemodynamic collapse during PCI. An alternative strategy of bailout pVAD support in the event of hemodynamic collapse is also entertained. METHODS We compared the outcomes of patients entered in the cVAD database who underwent Impella Protected PCI (ProPCI group) with patients from the cVAD and USpella databases receiving bailout Impella support for hemodynamic collapse during HRPCI (Bailout group). RESULTS A total of 1,028 patients supported with Impella pVAD were entered into the cVAD database as of July 2019 and were included in this analysis. Of those 971 were in the ProPCI group and 57 in the Bailout group. Patients in the Bailout group were more often female (50.9%vs. 27.2%, p = .0002) with higher median baseline left ventricular ejection fraction (LVEF) (40%vs. 30%, p
- Published
- 2021